Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer
Xiaofang Guo(Henan Medical University)
Cited by 27
Related Papers
Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy
|International Journal of Molecular Sciences|2018|40
Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma
|Oncology Reports|2012|20